Allopurinol in the prevention of pre-procedural myocardial injury following angioplasty

Phase 2

• Conditions: Ischemic heart diseases patients.; Ischaemic heart diseases; I20, I21,

• Registration Number: IRCT201412088307N11
• Lead Sponsor: Vice chancellor for research, Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Ischemic heart diseases patients; age 18-80; undergoing of angioplasty with stent insertion; filling of consent form.

Exclusion Criteria

Elevation of CK-MB and cTnI before PCI; history of CABG during last three months; history of previous MI; renal dysfunction (creatinine above 2.5 mg/dl); unsuccessful PCI; acute MI; cardiogenic shock; dialysis; pregnancy; inability in filling and understanding of the consent form; unconsented patients; patients who want to discontinue the study at any time

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CK-MB level. Timepoint: 12 hours Before, 8 and 24 hours after angioplasty. Method of measurement: ELISA.;CTnI level. Timepoint: Before, 8 and 24 hours after angioplasty. Method of measurement: ELISA.